Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin [PMID: 22962027] Laboratory literature summary: Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected
Full dose ladder (pharmacy passthrough at OBP wholesale, no markup): 12mg vial $45 24mg $90 34mg $127.50 44mg $165 56mg $210 66mg $247.50 30mg/3mL $112.50 52.5mg $196.88 60mg $225 180mg $675
Researchers planning protocols are referred to the original primary literature cited in the References section for full methodological detail
Its known in regenerative medicine for its potential to: Support soft tissue and joint repair Promote better healing after injury Reduce inflammation and discomfort BPC-157 is often used as part of a broader recovery strategy that may include stem cell therapy, particularly therapies using umbilical cord-derived stem cells one of the most potent and versatile sources available today
US$ 25.70
US$ 29.95
US$ 23.44
US$ 27.25
US$ 22.80
US$ 23.31
US$ 28.50
US$ 23.54
US$ 25.18
US$ 28.43
US$ 22.66
US$ 28.73
US$ 27.18
US$ 24.76
